Pilgrims Pride Corporation (PPC) is a publicly traded Consumer Defensive sector company. As of July 26, 2026, PPC trades at $28.69 with a market cap of $6.82B and a P/E ratio of 6.29. PPC moved +2.67% today. Year to date, PPC is -26.44%; over the trailing twelve months it is -39.35%. Its 52-week range spans $26.50 to $57.16. Analyst consensus is neutral with an average price target of $35.50. Rallies surfaces PPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Metapa Facility to Produce 100M Sterile Flies Weekly, Backed by $84M U.S. Funding: The U.S. and Mexico opened a Metapa facility to produce 30 million sterile screwworm flies weekly in July, scaling to 100 million by November. Together with the Panama plant, output will reach 200 million weekly, backed by $84 million in U.S. funds to avert livestock losses exceeding $700 million annually.
| Metric | Value |
|---|---|
| Price | $28.69 |
| Market Cap | $6.82B |
| P/E Ratio | 6.29 |
| EPS | $4.56 |
| Dividend Yield | 2.10% |
| 52-Week High | $57.16 |
| 52-Week Low | $26.50 |
| Volume | 813.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $18.50B |
| Net Income | $1.08B |
| Gross Margin | 12.75% |
5 analysts cover PPC: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $35.50.